First United Bank & Trust Bristol Myers Squibb CO Transaction History

First United Bank & Trust

  • $272 Million
  • Q3 2024

A detailed history of First United Bank & Trust transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, First United Bank & Trust holds 8,946 shares of BMY stock, worth $525,845. This represents 0.17% of its overall portfolio holdings.

Number of Shares
8,946
Previous 9,796 8.68%
Holding current value
$525,845
Previous $406,000 13.79%
% of portfolio
0.17%
Previous 0.15%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024
SELL
$39.66 - $51.75 $33,711 - $43,987
-850 Reduced 8.68%
8,946 $462,000
Q2 2024

Aug 12, 2024
SELL
$40.25 - $52.99 $24,069 - $31,688
-598 Reduced 5.75%
9,796 $406,000
Q1 2024

Apr 29, 2024
SELL
$47.98 - $54.4 $185,682 - $210,528
-3,870 Reduced 27.13%
10,394 $563,000
Q4 2023

Feb 07, 2024
SELL
$48.48 - $57.85 $352,546 - $420,685
-7,272 Reduced 33.77%
14,264 $731,000
Q3 2023

Oct 24, 2023
SELL
$57.89 - $64.73 $22,577 - $25,244
-390 Reduced 1.78%
21,536 $1.25 Million
Q2 2023

Jul 13, 2023
SELL
$63.71 - $70.74 $15,226 - $16,906
-239 Reduced 1.08%
21,926 $1.4 Million
Q1 2023

Apr 18, 2023
SELL
$65.71 - $74.53 $6,899 - $7,825
-105 Reduced 0.47%
22,165 $1.54 Million
Q4 2022

Jan 19, 2023
SELL
$68.48 - $81.09 $37,253 - $44,112
-544 Reduced 2.38%
22,270 $0
Q3 2022

Oct 25, 2022
SELL
$0.13 - $76.84 $95 - $56,477
-735 Reduced 3.12%
22,814 $1.62 Million
Q2 2022

Jul 18, 2022
SELL
$72.62 - $79.98 $86,272 - $95,016
-1,188 Reduced 4.8%
23,549 $1.81 Million
Q1 2022

Apr 20, 2022
SELL
$61.48 - $73.72 $36,273 - $43,494
-590 Reduced 2.33%
24,737 $1.81 Million
Q4 2021

Jan 20, 2022
SELL
$53.63 - $62.52 $21,988 - $25,633
-410 Reduced 1.59%
25,327 $1.58 Million
Q3 2021

Oct 14, 2021
BUY
$59.17 - $69.31 $33,431 - $39,160
565 Added 2.24%
25,737 $1.52 Million
Q2 2021

Jul 19, 2021
SELL
$61.91 - $67.42 $52,685 - $57,374
-851 Reduced 3.27%
25,172 $1.68 Million
Q1 2021

Apr 20, 2021
BUY
$59.34 - $66.74 $166,389 - $187,138
2,804 Added 12.08%
26,023 $1.64 Million
Q4 2020

Jan 19, 2021
SELL
$57.74 - $65.43 $1,154 - $1,308
-20 Reduced 0.09%
23,219 $1.44 Million
Q3 2020

Oct 13, 2020
SELL
$57.43 - $63.64 $22,340 - $24,755
-389 Reduced 1.65%
23,239 $1.4 Million
Q2 2020

Jul 14, 2020
SELL
$54.82 - $64.09 $18,090 - $21,149
-330 Reduced 1.38%
23,628 $1.39 Million
Q1 2020

Apr 13, 2020
SELL
$46.4 - $67.43 $30,902 - $44,908
-666 Reduced 2.7%
23,958 $1.34 Million
Q4 2019

Jan 13, 2020
SELL
$49.21 - $64.19 $119,580 - $155,981
-2,430 Reduced 8.98%
24,624 $1.58 Million
Q3 2019

Oct 11, 2019
SELL
$42.77 - $50.71 $426,844 - $506,085
-9,980 Reduced 26.95%
27,054 $1.37 Million
Q2 2019

Jul 09, 2019
SELL
$44.62 - $49.34 $85,447 - $94,486
-1,915 Reduced 4.92%
37,034 $1.68 Million
Q1 2019

Apr 11, 2019
SELL
$45.12 - $53.8 $23,101 - $27,545
-512 Reduced 1.3%
38,949 $1.86 Million
Q4 2018

Jan 15, 2019
SELL
$48.76 - $63.23 $37,984 - $49,256
-779 Reduced 1.94%
39,461 $2.05 Million
Q3 2018

Oct 15, 2018
BUY
$55.19 - $62.25 $97,631 - $110,120
1,769 Added 4.6%
40,240 $2.5 Million
Q2 2018

Jul 12, 2018
SELL
$50.53 - $62.98 $41,283 - $51,454
-817 Reduced 2.08%
38,471 $2.13 Million
Q1 2018

Apr 18, 2018
BUY
$59.92 - $68.98 $5,992 - $6,898
100 Added 0.26%
39,288 $2.49 Million
Q4 2017

Jan 16, 2018
BUY
$59.94 - $65.35 $65,934 - $71,885
1,100 Added 2.89%
39,188 $2.4 Million
Q3 2017

Oct 17, 2017
BUY
$55.23 - $63.74 $2.1 Million - $2.43 Million
38,088
38,088 $2.43 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track First United Bank & Trust Portfolio

Follow First United Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First United Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on First United Bank & Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email